| Metric | Q4 FY26 | Q3 FY26 | Q4 FY25 |
|---|---|---|---|
| Revenue from operations | 717.4 | 739.6 | 666.0 |
| Other income | 15.8 | 15.3 | 15.4 |
| Total income | 733.2 | 755.0 | 681.4 |
| Profit before exceptional items & tax | 95.5 | 109.5 | 111.3 |
| Exceptional items | 0.0 | 0.0 | -3.7 |
| Profit before tax | 95.5 | 109.5 | 107.6 |
| Net profit | 67.5 | 81.1 | 77.0 |
| Operating margin | 13.0% | 14.5% | 15.8% |
A dash means the filing did not report that period; n/m means not meaningful (margin on near-zero revenue). Growth is not shown when either period was a loss. Operating profit excludes other income.
| Net profit, year on year | -12.30% |
|---|---|
| Net profit, quarter on quarter | -16.80% |
| Revenue, year on year | +7.70% |
BSE results filing, NSE: JYOTHYLAB. Figures extracted from the filing.
Jyothy Labs Ltd: key numbers
- Share price
- ₹191.07
- Market cap
- ₹7,016 Cr
- Revenue (annual)
- ₹2,944 Cr
- Net profit (annual)
- ₹333.2 Cr
- P/E (TTM)
- 24.7×Sector 43.4×
- Promoter holding
- 62.89%+0.00% QoQ
- FII holding
- 12.13%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Jyothy Labs Ltd
All →Jyothy Labs Credit Rating
CARE Ratings has reaffirmed Jyothy Labs Limited's 'CARE AA; Stable' rating for its long-term bank facilities. The rating applies to facilities totaling Rs. 250 crore.
- Value
- ₹250.0 Cr
Jyothy Labs Employee Stock Options
Jyothy Labs has granted 1,46,141 Restricted Stock Units (RSUs) to eligible employees under its RSU Plan 2023. These units vest over a period of up to four years.
Jyothy Labs Capital Structure Change
Nalanda India Equity Fund Limited acquired a 0.85% stake in Jyothy Laboratories Limited. The acquisition of 3,102,384 shares increases the fund's total holding to 7.61%.
Jyothy Labs Other Announcement
Jyothy Labs has been assigned an ESG rating of '67' by NSE Sustainability Ratings & Analytics Limited. This rating was derived independently using public domain data.
Jyothy Labs Earnings Call Transcript: Key Takeaways
Management is firefighting severe gross margin contraction caused by extreme crude-oil linked inflation, relying on price hikes and channel expansion while facing aggressive competitive discounting.
- Call
- Guides 10% growth
Jyothy Labs Investor Presentation: Key Takeaways
Jyothy Labs reported 3% revenue growth for Q1 FY27, driven by Fabric Care. EBITDA and PAT saw significant declines of 47.9% and 50.8% respectively due to abnormal raw material and packaging inflation.